Lead Product(s) : L-Histidine
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Histidine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Renal Insufficiency.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
August 13, 2018
Lead Product(s) : L-Histidine
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-Histidine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Essential Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
Details : Histidine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Coronary Artery Disease.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
September 07, 2012
Lead Product(s) : L-Histidine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Essential Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L-Histidine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Jazz Pharmaceuticals | Association AIRE
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Histidine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Coronary Stenosis.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
July 25, 2011
Lead Product(s) : L-Histidine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Jazz Pharmaceuticals | Association AIRE
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
